Ladenburg Thalmann & Co. Inc.
277 Park Avenue, 26th Floor
New York, New York 10172
October 7, 2020
VIA FACSIMILE AND EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Washington, DC 20549
|
| Re: | ARTELO BIOSCIENCES, INC. |
Ladies and Gentlemen:
Ladenburg Thalmann & Co. Inc. (“Ladenburg”), as representative of the underwriters for the referenced offering, hereby concurs in the request by Artelo Biosciences, Inc. that the effective date of the above-referenced registration statement be accelerated to 5:30 p.m. (Eastern Time), or as soon as practicable thereafter, on October 8, 2020, pursuant to Rule 461 under the Securities Act. Ladenburg affirms that it is aware of its obligations under the Securities Act in connection with this offering.
|
| Very truly yours, |
| |
|
|
|
|
|
|
| LADENBURG THALMANN & CO. INC. |
| |
|
|
|
|
|
|
| By: | /s/ Nicholas Stergis |
|
|
| Name: | Nicholas Stergis |
|
|
| Title: | Managing Director |
|